This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
Number of new molecular entities launched in the U.S. from 2003 to 2015
This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
Loading statistic...
| New Mechanism | Orphan | Existing Mechanism | |
|---|---|---|---|
| 2003 | 13 | 6 | 5 |
| 2004 | 12 | 5 | 3 |
| 2005 | 11 | 4 | 6 |
| 2006 | 10 | 9 | 9 |
| 2007 | 6 | 5 | 7 |
| 2008 | 7 | 6 | 7 |
| 2009 | 8 | 7 | 18 |
| 2010 | 9 | 8 | 9 |
| 2011 | 11 | 12 | 10 |
| 2012 | 12 | 8 | 8 |
| 2013 | 8 | 17 | 11 |
| 2014 | 7 | 20 | 18 |
| 2015 | 14 | 15 | 14 |
© Statista 2018
More information
Other interesting statistics
+Top pharmaceutical companies located in Canada by revenue 2016
+World pharmaceutical sales 2015-2017 by region
+Top 50 pharmaceutical companies - Rx sales and R&D spending 2016
+Pfizer's total revenue 2006-2017
+Johnson & Johnson's total revenue 2005-2017
+Leading countries in life sciences sector M&As 2017
Statista Accounts: Access All Statistics. Starting from $588 / Year
Statistics on "U.S. pharmaceutical industry"
Statista for Your Company: The Research and Analysis Tool
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Availability of new medicines in selected countries 2013
- Changes in prescriptions for U.S. young adults
- U.S. insured patients' out-of-pocket health spending 2008-2011
- Changes in prescriptions for older people in the U.S. 2011
- Global pharmaceutical product launches by therapy area 2004-2013
- Medicine spending share globally in 2007,2017 and 2022, by country group
- Top therapy spending areas in pharmerging markets 2018
- Standard Unit medicine use per capita in the U.S. 2007-2011
- Prescription per capita in the United States by age group 2013
- Reasons for rejected payer retail prescriptions in the U.S. in select classes 2013
- Medicinal market growth worldwide including rebates 2009-2018
- Top therapy areas in the U.S. by number of prescriptions 2016
- New medicine availability by therapy area in the U.S. 2013
- Total and per capita change in U.S. prescriptions 2004-2013
- Medicinal market growth by world region, specialty and traditional 2013-2018
- Canada: B2B magazine launches 2002-2012, by interest category
- Production value of metabolic and nutrient agents in Taiwan 2008-2017
- Volume of general medicine drugs consumed in Europe 2014
- Domestic demand of surface-active agents Japan 2012-2016
- Direct export value of glucose reagent from Taiwan 2008-2017